| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/17/2009 | CN101455670A Use of natural 2beta,3alpha,7beta,19alpha- tetrahydroxy-ursol-12-ene-28-carboxylate and composition thereof |
| 06/17/2009 | CN101455669A Mediation for treating acne |
| 06/17/2009 | CN101455668A Preparation of trimetazidine hydrochloride sustained-release tablets and use thereof |
| 06/17/2009 | CN101455667A Preparation of trimetazidine hydrochloride gastric floating tablets and use thereof |
| 06/17/2009 | CN101455666A Nimodipine double-layer osmotic pump controlled release tablet and preparation technique thereof |
| 06/17/2009 | CN101455665A Preparation method of pidotimod dispersible table and use thereof |
| 06/17/2009 | CN101455664A Preparation method of ornidazole gastric floating tablets and use thereof |
| 06/17/2009 | CN101455663A Preparation process of butoconazole nitrate vagina plug and use thereof |
| 06/17/2009 | CN101455662A Preparation process of butoconazole nitrate vagina effervescence tables and use thereof |
| 06/17/2009 | CN101455661A Use of 3-substituted phthalide and the analogue |
| 06/17/2009 | CN101455660A Use of glaucocalyxin X in preparing anti-cancer medicine |
| 06/17/2009 | CN101455659A Preparation method of gefarnate sustained-release tables and use thereof |
| 06/17/2009 | CN101455658A Use of salvianolic acid A and medicine composition thereof from Salia miliiorrhiza Bge. |
| 06/17/2009 | CN101455657A Use of salvianolic acid A and medicine composition containing salvianolic acid A from Salia miliiorrhiza Bge. |
| 06/17/2009 | CN101455656A Preparation method of gefarnate gastric floating tablets and use thereof |
| 06/17/2009 | CN101455655A Creatine sustained-release preparation and preparation process thereof medication |
| 06/17/2009 | CN101455654A Arginine ibuprofen gel and preparation method thereof |
| 06/17/2009 | CN101455653A Arginine ibuprofen oral disintegrating tablets and preparation method thereof |
| 06/17/2009 | CN101455652A Use of diterpenoids from Isodon japonica var.galaucocalyx in preparing anti-cancer medicine |
| 06/17/2009 | CN101455649A Disposal systems of transdermal delivery devices to prevent misuse of the active agents contained therein |
| 06/17/2009 | CN100500694C Disialoundecasaccharide chain asparagine/fatty acid amide and medical drug containing same |
| 06/17/2009 | CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage |
| 06/17/2009 | CN100500669C Salviolic acid berberine compound salt, its preparation method and application |
| 06/17/2009 | CN100500663C N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl) -n-phenylamines as antiproliferative compounds |
| 06/17/2009 | CN100500658C Pharmaceutical composition of male sexual dysfunction |
| 06/17/2009 | CN100500654C Tetrahydrocarbazol derivatives as ligands for g-protein-coupled receptors (gpcr) |
| 06/17/2009 | CN100500651C Crystalline and pure modafinil and process of preparing the same |
| 06/17/2009 | CN100500644C Interconnected medicine precursor of gabapentin and pregabalin and its medicinal use |
| 06/17/2009 | CN100500246C Use of dapsone as a neuroprotector in cerebral apoplexy |
| 06/17/2009 | CN100500221C Bioerodible film for ophthalmic drug delivery |
| 06/17/2009 | CN100500161C Azithromycin micro-pill capsule and its preparing method |
| 06/17/2009 | CN100500160C Medicinal composition containing epimedium active constituent and its application |
| 06/17/2009 | CN100500159C Novel application for apigenin-7-O-beta-D-glucoside-4'-O-alpha-L-rhamnoside |
| 06/17/2009 | CN100500158C Aspirin slow-release tablet and its preparation method |
| 06/17/2009 | CN100500157C Water-soluble medicine slow release tablet and its preparation method |
| 06/17/2009 | CN100500156C Galanthamine hydrobromide composition and its preparing method |
| 06/17/2009 | CN100500155C Slowly releasing allopurinol tablet and its preparation |
| 06/17/2009 | CN100500154C Pharmaceutical composition for treating or preventing respiratory and digestive diseases of birds and livestocks |
| 06/17/2009 | CN100500153C Oral chewy composition for covering unflavored taste and preparation method |
| 06/17/2009 | CN100500152C Dextromethorphan hydrobromide nose drops |
| 06/17/2009 | CN100500151C Water-soluble medicine sublingual-medicating formulation |
| 06/17/2009 | CN100500150C Medicinal composition for treating cold wet numbness and its production |
| 06/17/2009 | CN100500149C Composition of leukotrienes antagonist oral liquid |
| 06/17/2009 | CN100500148C A buffered, liquid nicotine composition for pulmonary administration |
| 06/17/2009 | CN100500147C New formulations and use thereof |
| 06/17/2009 | CN100500146C Application of Vinpocetine and its derivant for treatment and prophylaxis of epilepsy and its complication |
| 06/17/2009 | CN100500145C 'Yanhuning' frozen-dried powder injection and its preparation method |
| 06/17/2009 | CN100500144C Ibuprofen granule and preparing method thereof |
| 06/17/2009 | CN100500143C Buluoweima slow-release tablet and its preparing method |
| 06/17/2009 | CN100500142C Preparation and purification of synthetic capsaicin |
| 06/17/2009 | CN100500141C Plant-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 06/17/2009 | CN100500140C Dermal compositions containing coenzyme Q as active ingredient |
| 06/17/2009 | CN100500130C Sustained-release preparations and method for producing the same |
| 06/17/2009 | CN100500113C Stainless steel cardiovascular bracket with pharmaceutical coating on surface and preparation method thereof |
| 06/16/2009 | US7547819 Transforming a plant cell using an expression recombinant vector including a DNA encoding hyaluronic acid synthase, growing a transformant obtained then separating the hyaluronic acid produced |
| 06/16/2009 | US7547806 Formed by combining solution of tannic acid with rasagiline base to form mixture, removing part of liquid, adding polar, water soluble solvent to form second mixture, removing liquid at ambient temperature from second mixture; selective inhibitor of B-form of enzyme monoamine oxidase; Parkinson's disease |
| 06/16/2009 | US7547804 pro-apoptotic compounds; e.g. tumors, autoimmune diseases, viral infection, psoriasis; N-(substituted phenyl)-2-hydroxybenzamides e.g. 5-Chloro-2-hydroxy-N-(4-((2-methoxyethyl)-methylamino)-2-(2-(3-trifluoromethylphenyl)ethoxy)phenyl)benzamide |
| 06/16/2009 | US7547802 Compounds for the treatment of metabolic disorders |
| 06/16/2009 | US7547788 Alkyl substituted piperidine derivatives and their use as monoamine neurotransmitter re-uptake inhibitors |
| 06/16/2009 | US7547787 Processes for preparing montelukast sodium |
| 06/16/2009 | US7547779 Preparation of 1,6-disubstituted azabenzimidazoles as kinase inhibitors |
| 06/16/2009 | US7547765 For modifying polypeptides; shikimic acid, quinic acid, or carbohydrate derivatives of polyalkylene glycols; improves bioavailability of modified peptides such as enzyme, a cytokine or a hormone e.g. interferon beta or granulocyte colony stimulating factor; biodrugs |
| 06/16/2009 | US7547763 Sequences of an Ih ion channel and use thereof |
| 06/16/2009 | US7547731 Antiinflammatory agents; antiallergens; respiratory system disorders |
| 06/16/2009 | US7547730 Preventive and/or therapeutic treatment of hyperlipidemia or non-insulin dependent diabetes mellitus which comprises dministering orally a polyprenyl compound 3,7,11,15-tetramethyl-2,4,6,10,14-hexadecapentaenoic acid (NIK-333); antidiabetic and -lipemic agents |
| 06/16/2009 | US7547729 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same |
| 06/16/2009 | US7547728 (N-(4-nitro-3-trifluoromethyl)phenyl)-(2S)-3-(4- (acetylamino) phenoxy)-2-hydroxy-2-methylpropanamide) derivatives |
| 06/16/2009 | US7547727 Therapeutic cyclopentane derivatives |
| 06/16/2009 | US7547726 AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure |
| 06/16/2009 | US7547725 Fluoro- and trifluoroalkyl-containing heterocyclic sulfonamide inhibitors of beta amyloid production and derivatives thereof |
| 06/16/2009 | US7547724 IAP BIR domain binding compounds |
| 06/16/2009 | US7547723 Comprehensive pharmacologic therapy for treatment of a dysfunction |
| 06/16/2009 | US7547722 Chemical compounds |
| 06/16/2009 | US7547721 Near infrared fluorescent contrast agent and fluorescence imaging |
| 06/16/2009 | US7547720 di-tert-butyl 4-{[1-(3,3-dimethyl-2-oxobutyl)-6-methoxy-1-H-indazole-3-yl]carbonyl}benzylphosphate; potassium channel blocker; eye neuroprotectant; hypotensive agent; glaucoma, elevated intraoccular pressure in the eye |
| 06/16/2009 | US7547719 Thrombopoietin mimetic; useful as an agonist of the TPO receptor, particularly in enhancing platelet production; treatment of thrombocytopenia |
| 06/16/2009 | US7547718 Substituted imidazoles |
| 06/16/2009 | US7547717 2-thioxo-4-imidazolines; angina, hypertension, congestive heart failure, myocardial ischemia, arrhythmia, diabetes, urinary incontinence, stroke, pain, brain injury, or neuronal disorders |
| 06/16/2009 | US7547716 Sulfonamide derivatives |
| 06/16/2009 | US7547715 Treating lung diseases selected from acute pneumonia, pulmonary fibrosis, pulmonary hypertension, chronic obstructive pulmonary disease (COPD), and asthma by administering (E)-[5-[2-[1-phenyl-1-(3-pyridyl)methylideneaminoxy]ethyl]-7,8-dihydronaphthalen-1-yloxy]acetic acid or a salt thereof |
| 06/16/2009 | US7547714 (4 beta S,7R,8 alpha R)-4 beta -benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4 beta ,5,6,7,8,8 alpha ,9,10-octahydrophenanthrene-2-carboxamide; glucocorticoid receptor modulators; antiinflammatory agents; Alzheimer's disease |
| 06/16/2009 | US7547713 O-pyridinequinone derivatives, the composition containing the derivatives, the process for preparation of the derivatives and the use of the derivatives |
| 06/16/2009 | US7547712 Reducing adverse effect of nicotine on fetus by administering a nicotine-carrier conjugate to a human pregnant with a fetus, wherein carrier is an immunogenic protein, and wherein adverse effect is selected from low birth weight, premature delivery/birth, post-natal nicotine withdrawal |
| 06/16/2009 | US7547711 Heterocyclic inhibitors of kinases |
| 06/16/2009 | US7547710 Such as (2E)-3-[3-(aminomethyl)-2-isobutyl-4-(4-methylphenyl)quinolin-6-yl]acrylamide; dipeptidyl peptidase IV inhibitors; diabetes, obesity, glucose intolerance |
| 06/16/2009 | US7547709 Prevent free radical cellular damage; oxidation resistant additive for fuels, lubricants, rubbers, polymers, solvents, chemical and foodstuff; lipid and water soluble vitamin c, vitamin e |
| 06/16/2009 | US7547708 N-sulfamoyl-N′-benzopyranpiperidine compounds and uses thereof |
| 06/16/2009 | US7547707 Spirocyclic cyclohexane compounds |
| 06/16/2009 | US7547706 1H-pyrimido[4,5-b]indole derivatives, their preparation and therapeutic use |
| 06/16/2009 | US7547705 Ethyl-1'-[(2S)-2-hydroxy-2-phenylethyl]-6'-oxo-8'-(pyridin-4-yl)-1',3',4',6'-tetrahydro-1H-spiro[piperidine-4,2'-pyrimido[1,2-a]pyrimidine]-1-carbox; glycogen synthase kinase-3 beta, amyloid precursor protein, tau protein hyperphosphorylation inhibitor; neurodegenerative disease, type II diabetes |
| 06/16/2009 | US7547703 Indoline derivatives substituted in the 6-position, their preparation and their use as medicaments |
| 06/16/2009 | US7547702 Glycoprotein antagonist; anticholesterol agents; cardiovascular disorders; strokes; antiischemic agents |
| 06/16/2009 | US7547701 cathepsin S inhibitors; e.g. N-(1-cyanocyclopropyl)-3-phenylmethanesulfonyl-2-(2,2,2-trifluoro-1-phenylethylamino)-propionamide; autoimmune diseases such as rheumatoid arthritis or multiple sclerosis, pain, or atherosclerosis |
| 06/16/2009 | US7547700 Such as (3-chloro-4-fluorophenyl)(4-fluoro-4-{[(5-hydoxypyridin-2-ylmethyl)amino]methyl}piperidin-1-yl)methanone; serotonin receptor agonists; for treating depression, pain, and substance abuse |
| 06/16/2009 | US7547698 Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD) |
| 06/16/2009 | US7547697 Alkyl-pyridazine derivatives as 11b-HSD1 inhibitors |
| 06/16/2009 | US7547696 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 06/16/2009 | US7547695 Pyridopyrimidinones |
| 06/16/2009 | US7547694 Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions |
| 06/16/2009 | US7547693 Piperidine derivative |